• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients.

作者信息

Nash Tammon, Hoffmann Sandra, Butch Suzanne, Davenport Robertson, Cooling Laura

出版信息

Transfusion. 2012 Oct;52(10):2270-2. doi: 10.1111/j.1537-2995.2012.03739.x.

DOI:10.1111/j.1537-2995.2012.03739.x
PMID:23110735
Abstract
摘要

相似文献

1
Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients.白细胞滤除且未经巨细胞病毒（CMV）检测的成分在CMV阴性的异基因人类祖细胞移植受者中的安全性。
Transfusion. 2012 Oct;52(10):2270-2. doi: 10.1111/j.1537-2995.2012.03739.x.
2
Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients.在异基因造血移植受者中输注来自巨细胞病毒未筛查供者的去白细胞细胞血液成分：72例受者的分析
Bone Marrow Transplant. 2005 Sep;36(6):499-501. doi: 10.1038/sj.bmt.1705090.
3
Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.为巨细胞病毒阴性的异基因骨髓移植受者使用经过滤的未筛查血液制品提供输血支持。
Bone Marrow Transplant. 1998 Sep;22(6):575-7. doi: 10.1038/sj.bmt.1701361.
4
Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?在普遍白细胞去除术时代，造血干细胞移植受者是否仍需要对血液制品进行巨细胞病毒检测？
Biol Blood Marrow Transplant. 2013 Dec;19(12):1719-24. doi: 10.1016/j.bbmt.2013.09.013. Epub 2013 Oct 5.
5
Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME).去白细胞血液制品传播未检测抗巨细胞病毒抗体的巨细胞病毒感染：高危患者行异基因造血干细胞移植（CME）的单中心前瞻性研究。
Transfusion. 2011 Dec;51(12):2620-6. doi: 10.1111/j.1537-2995.2011.03203.x. Epub 2011 Jun 3.
6
Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.在监测和抢先治疗时代，移植前巨细胞病毒（CMV）血清学状态仍然是异基因造血干细胞移植后CMV重新激活的最重要决定因素。
Transpl Infect Dis. 2010 Aug 1;12(4):322-9. doi: 10.1111/j.1399-3062.2010.00504.x. Epub 2010 May 11.
7
Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study.床边白细胞去除术对预防异基因骨髓移植受者巨细胞病毒传播的作用：一项回顾性研究
Haematologica. 2001 Jul;86(7):749-52.
8
Cytomegalovirus infection following stem cell transplantation.干细胞移植后的巨细胞病毒感染
Haematologica. 1999 Jun;84 Suppl EHA-4:46-9.
9
Re-examining the relationship between active cytomegalovirus (CMV) infection and acute graft-versus-host disease in allogeneic stem cell transplant recipients in the era of real-time PCR CMV assays.
Transpl Int. 2016 Jan;29(1):126-8. doi: 10.1111/tri.12689. Epub 2015 Oct 7.
10
A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.过滤白细胞去除血制品与巨细胞病毒（CMV）血清学阴性血制品预防骨髓移植后输血相关CMV感染的比较。
Blood. 1995 Nov 1;86(9):3598-603.

引用本文的文献

1
Comparing transfusion reactions between pre-storage and post-storage leukoreduced apheresis platelets: an analysis using propensity score matching.比较储存前和储存后去白细胞机采血小板的输血反应：采用倾向评分匹配的分析。
Ann Hematol. 2024 Apr;103(4):1389-1396. doi: 10.1007/s00277-024-05652-9. Epub 2024 Feb 23.
2
Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis.献血者巨细胞病毒血清流行率：系统评价和荟萃分析。
J Int Med Res. 2021 Aug;49(8):3000605211034656. doi: 10.1177/03000605211034656.
3
Transfusion in Neonatal Patients: Review of Evidence-Based Guidelines.
新生儿患者输血：循证指南综述。
Clin Lab Med. 2021 Mar;41(1):15-34. doi: 10.1016/j.cll.2020.10.002. Epub 2020 Dec 23.
4
Transfusion-transmitted cytomegalovirus: behaviour of cell-free virus during blood component processing. A study on the safety of labile blood components in Switzerland.经输血传播的巨细胞病毒：血液成分处理过程中游离病毒的行为。对瑞士不稳定血液成分安全性的研究。
Blood Transfus. 2020 Nov;18(6):446-453. doi: 10.2450/2020.0241-19. Epub 2020 Feb 28.
5
Leucoreduction of blood components: an effective way to increase blood safety?血液成分白细胞滤除：提高血液安全性的有效方法？
Blood Transfus. 2016 May;14(2):214-27. doi: 10.2450/2015.0154-15. Epub 2015 Dec 16.
6
Prevention of Transfusion-Transmitted Cytomegalovirus Infections: Which is the Optimal Strategy?预防输血传播的巨细胞病毒感染：哪种是最佳策略？
Transfus Med Hemother. 2014 Feb;41(1):40-4. doi: 10.1159/000357102. Epub 2013 Dec 19.